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Continuous exposure to low levels of Cryptosporidium 
oocysts is associated with production of protective antibod-
ies. We investigated prevalence of antibodies against the 
27-kDa Cryptosporidium oocyst antigen among blood do-
nors in 2 areas of Scotland supplied by drinking water from 
different sources with different filtration standards: Glasgow 
(not filtered) and Dundee (filtered). During 2006–2009, se-
roprevalence and risk factor data were collected; this period 
includes 2007, when enhanced filtration was introduced to 
the Glasgow supply. A serologic response to the 27-kDa an-
tigen was found for ≈75% of donors in the 2 cohorts com-
bined. Mixed regression modeling indicated a 32% step-
change reduction in seroprevalence of antibodies against 
Cryptosporidium among persons in the Glasgow area, 
which was associated with introduction of enhanced filtra-
tion treatment. Removal of Cryptosporidium oocysts from 
water reduces the risk for waterborne exposure, sporadic 
infections, and outbreaks. Paradoxically, however, oocyst 
removal might lower immunity and increase the risk for in-
fection from other sources.
Each year since 2005, Health Protection Scotland has received reports of 500–700 laboratory-confirmed cas-
es of cryptosporidiosis (10–14 cases/100,000 population/
year); seasonality is usually markedly biphasic, peaking in 
spring and early autumn. Cryptosporidiosis is caused by >1 
species/genotypes of the protozoan parasite in the genus 
Cryptosporidium, which infects a wide variety of animals 
including humans. The most common human pathogens 
are Cryptosporidium hominis and C. parvum. Character-
istic signs of infection are profuse, watery diarrhea, often 
accompanied by bloating, abdominal pain, and nausea or 
vomiting. Illness is typically self-limiting but can last for 
2–3 weeks; studies suggest an association with long-term 
health sequelae, such as reactive arthritis and postinfection 
irritable bowel syndrome (1,2). Moreover, severe, chronic 
diarrhea or even life-threatening wasting and malabsorp-
tion can develop in persons with severely compromised im-
mune systems, particularly those with reduced T-lympho-
cyte counts, in the absence of immunotherapy (3).
Drinking water contaminated with Cryptosporidium 
oocysts is a recognized risk factor for human illness (4–
6). Before or after treatment, water can be contaminated 
by a variety of sources, including livestock, feral animals, 
or humans (7). Oocysts can remain infectious in the envi-
ronment for prolonged periods and are resistant to regular 
drinking-water disinfection treatments. For preventing 
human exposure, oocysts must be physically removed 
from water supplies; however, inadequate water filtration 
can expose persons to risk for infection from viable oo-
cysts (8–11). 
Where drinking-water filtration has been enhanced 
to reduce oocysts counts, the incidence of reported clini-
cal Cryptosporidium infection has been reduced (6,11). 
However, reported rates of infection are subject to varia-
tion, depending on factors such as local laboratory testing 
criteria, and exposure source attribution depends on the 
quality of risk-factor exposure data. Therefore, assessing 
trends in clinical infection rates might not be sufficiently 
sensitive for detecting changes in single-exposure risks. 
Variations in other risk factors (e.g., foreign travel, direct 
animal contact) can also obscure an effect associated with 
reduced exposure to oocysts in drinking water. Assess-
ment of the effects of changes in environmental oocyst 
exposure would ideally be based on measuring popula-
tion-level indicators, rather than relying on reported (self-
selected) cases of laboratory-confirmed cryptosporidiosis. 
Alternatively, longitudinal variation in levels of antibody 
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to Cryptosporidium oocyst proteins could be used to de-
tect associations with variations in oocyst exposure.
The association between seropositivity and exposure 
to Cryptosporidium oocysts in drinking water has been 
investigated. Low levels of oocysts have been detected in 
65%–97% of surface-water supplies, suggesting that many 
populations may be at risk (12). Elevated serologic re-
sponses have been detected in those whose drinking-water 
source is surface water rather than groundwater. The risk 
for oocyst exposure might therefore be higher for surface 
water than for groundwater sources (13–15), even after 
conventional filtration (13). However, chronic low-level 
exposure to oocysts in environmental sources, including 
drinking water, can stimulate protective immunity. Strong 
serologic responses to oocyst antigens have been associ-
ated with such environmental exposures (16,17).
To decrease the risk for waterborne Cryptosporidium 
infection from drinking-water supplies, the water indus-
try established several barrier water treatment systems. 
In Scotland, water treatment has significantly reduced the 
concentration of Cryptosporidium oocysts in final (post-
treatment) tap water. Before September 2007, however, the 
Loch Katrine system, which supplies the towns of Glasgow 
and Clyde, did not have such a filtration treatment. The risk 
from drinking unfiltered water was demonstrated in 2000, 
when an outbreak of cryptosporidiosis occurred among 
Glasgow residents living within the Loch Katrine supply 
area (18). To decrease this risk, in September 2007, en-
hanced treatment (rapid gravity filtration and coagulation) 
was introduced to the Loch Katrine supply system. This 
new system provided an opportunity to assess the public 
health effects of improving the standard of water filtration.
We investigated the prevalence of antibodies to the 
27-kDa Cryptosporidium oocyst antigen among residents 
living in the Loch Katrine supply area (Glasgow) before 
and after the introduction of filtration and compared these 
with levels in a control population (Dundee) where no such 
change to drinking-water treatment occurred. Our main 
objective was to determine whether an association exists 
between prevalence of antibody response to the 27-kDa an-
tigen and the standard of drinking-water treatment (filtered 
vs. unfiltered).
Methods
Study Sites and Populations
The study received approval from the Multi-Research 
Ethics Committee for Scotland and was conducted from 
April 2006 through October 2008. Volunteer blood donors 
were recruited in Glasgow (population 580,000; western 
Scotland) and Dundee (population 142,000; eastern Scot-
land). Each area receives drinking water from a separate 
surface-sourced system. Before September 2007, the 
Glasgow water supply received only rough screening treat-
ment, but after that date, it was upgraded to match the spec-
ifications at Dundee (Clatto reservoir), the control system, 
which received rapid gravity filtration and coagulation. 
During the study period, no significant changes were made 
to the Dundee water treatment system, and no waterborne 
or other outbreaks of cryptosporidiosis were reported for 
either location. Blood samples for this study were collect-
ed during 4 periods (matched for seasonality): April–July 
2006 (period 1), August–October 2006 (period 2), April–
July 2008 (period 3), and August–October 2008 (period 4).
Waterborne Oocyst Data
Potential exposure to waterborne oocysts was assessed 
by examining data on oocyst counts, which was routinely 
collected from the respective supplies for regulatory pur-
poses. To reduce sampling bias, large sample volumes 
(≈1,000 L), collected before and after filtration, were used 
for oocyst detection. Filtamax filters (Genera Technologies, 
Newmarket, UK) were used for posttreatment water sam-
pling; Cuno (3M, Bracknell, UK) filters were used for pre-
treatment water sampling because of their higher turbidity. 
Blood Sample Collection and Donor Questionnaires
Blood donors from Glasgow and Dundee were in-
formed of the aims of the study and asked to consent to 
participate for the duration of the project. At each blood do-
nation session attended during the study period, volunteers 
were asked to confirm their agreement to allow a sample 
to be used for the study and to provide information about 
recent known exposure to potential risk factors for Cryp-
tosporidium infection. Blood samples (1 mL) were sent in 
heparinized containers to the Scottish Parasite Diagnostic 
Laboratory for analysis.
Western Blot 
Serum samples were analyzed by using immunob-
lot (mini-format) to measure IgG response to the 27-kDa 
antigen. The analytical methods are described elsewhere 
(14,16,17). However, because locally available human se-
rum for use as positive control was insufficient, the positive 
control was derived from serum from a rabbit that had been 
immunized with a soluble lysate of C. parvum in Freund’s 
complete adjuvant.
Before each blood collection period, fresh rabbit con-
trol serum was prepared, aliquoted, and frozen. Serum 
samples (Dundee and Glasgow) from each collection pe-
riod were tested in the same set of test runs, which enabled 
comparison of potential differences between the 2 geo-
graphic locations. Oocysts (Iowa isolate) were imported 
from the University of Arizona (Tucson, AZ, USA). The 
intensity of the serologic response to the antigen was digi-
tally analyzed by using a Gel Doc 2000 Imaging System 
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(Bio-Rad, Hercules, CA, USA). The intensity of each band 
was standardized by comparing the response intensity of 
each serum sample against a positive control (expressed as 
percentage positive response [PPR]). PPR standardization 
was performed by comparing the intensity of the study se-
rum band with that of the positive control band from the 
same blot.
Statistical Methods
To achieve a power of 95% for detecting a difference 
of at least 10% in seropositivity between prefiltration and 
postfiltration blood samples in the Glasgow cohort, 700 do-
nors were required from Glasgow and 290 from Dundee. 
These numbers were based on results of the McNemar test 
and an assumption that ≈30% of the prefiltration samples 
would be seropositive. According to results of a standard 
normal test for differences in proportions, the power to de-
tect a seropositivity difference between the cohorts of at 
least 10% would be >90%.
Several statistical methods, including univariate (χ2 
or Fisher exact test) and multivariate techniques, simulta-
neously considered several explanatory variables and se-
rologic values. The type of multivariate regression model 
used was dictated by the distribution of the response vari-
ables: linear regression for continuous (PPR) and logistic 
regression for binary (positive/negative) responses.
Each participant should have had serologic results 
from 4 periods, and results were expected to correlate with 
each other. To enable repeated observations from the same 
participants over time, we used mixed-effect regression 
models. These methods maximized the data at each period 
and accounted for new participants recruited to replace 
those lost to attrition.
Measurement of Seropositivity
Antibody levels in immunized rabbits are probably 
higher than those in humans exposed to low levels of oo-
cysts in the environment. Seropositivity was measured 
relative to the positive (rabbit serum) control (0 to >100% 
PPR). Some of the analyses used the actual PPR measure-
ments; others required a binary measure (positive/negative 
response). For the latter analyses, a PPR level had to be 
selected to designate what constituted a positive response. 
Seropositivity can therefore vary, depending on the cutoff 
threshold value used to compare with the positive control.
Other studies of Cryptosporidium antibody serop-
revalence that used serum from human patients rather than 
immunized rabbits have used a 20% cutoff threshold to 
designate positivity (13–15,19). In such studies, Crypto-
sporidium antibody seroprevalence has been 48%–76% of 
the study populations. Because our study used 20% PPR 
as the cutoff threshold, overall prevalence of antibodies 
against Cryptosporidium was similar for the entire study 
cohort (75%). Had the cutoff been increased to 30% PPR, 
then 64% of the entire cohort would have been designated 
as having a positive serologic response.
The choice of PPR cutoff threshold affected our abil-
ity to detect significant changes in the proportion of each 
cohort who were antibody positive. To determine what ef-
fect different PPR cutoffs would have on the analyses, we 
conducted a sensitivity analysis; as the PPR cutoff value 
increased, the chance of detecting a significant difference 
also increased.
Multivariate Analysis of Risk Factors and  
Serologic Responses
Logistic models were fitted to the logistic response by 
dichotomizing the response at different PPR cutoff values; 
those >20% were designated as positive. Within the logis-
tic models, we fitted a series of contrasts, which enabled 
us to test differences in serologic responses linked to dif-
ferences in risk factor exposures between the cohorts and 
between collection periods. From the 8 main observation 
categories (2 cities and 4 periods), 7 comparisons (con-
trasts) were generated and used to assess variations in the 
proportions of persons with a positive serologic response. 
The main study hypothesis was that the introduction of 
filtration to the Glasgow supply would be associated with 
a change in seroprevalence levels in the Glasgow cohort. 
The prefiltration/postfiltration effect in Glasgow, compared 
with this effect in Dundee, was the major comparison used 
in the sensitivity analysis for choosing the optimal PPR 
cutoff for the main statistical analyses. Analyses of loga-
rithmically transformed PPRs were used to identify relative 
differences across collection periods and city cohorts. We 
also compared the exposure risk profiles of those who had 
no (0) detectable responses with those who had some (>0) 
serologic responses by using χ2 tests.
Unless otherwise stated, we used R software version 
2.80 (www.R-project.org) for the statistical analysis and 
Minitab statistical software version 14 (www.minitab.com) 
for information collation. In general, a significance level of 
5% (p<0.05) was used for all analyses. However, because 
repeated tests were conducted for the same variable (the 
serologic response), the level used to assess statistical sig-
nificance was corrected by using the Bonferroni correction. 
Because there were 31 demographic risk factor questions, a 
corrected significance level of 0.0016 (0.05/31), rather than 
the standard 0.05, was used.
Results
Study Participants
The original cohort consisted of 791 blood donors 
from Glasgow and 260 from Dundee. However, not all the 
original participants remained in the study, and some were 
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replaced by new recruits (Table 1). The total number of 
study participants was therefore 1,437. Some participants 
did not donate blood during all 4 collection periods; others 
donated >1 time during some collection periods.
Oocyst Counts
Before September 2007, the oocyst detection rate in 
Clatto (final water) averaged 4.4 × 10–4 oocysts per 10 L 
(Table 2). During this period, consumers of Loch Katrine 
water were exposed to 13.2 × 10–4 oocysts per 10 L, which 
is 3 times higher. Therefore, the risk for waterborne infec-
tion was potentially greater for Glasgow residents. After 
filtration was introduced at Loch Katrine, the oocyst count 
decreased to zero in final water, representing complete re-
moval of waterborne oocysts. During this period, consum-
ers of Clatto water were also exposed to fewer oocytes (av-
erage 1.15 × 10–4 oocysts/10 L, reduced from the original 
4.4 × 10–4 oocysts/10 L). Thus, both cohorts were exposed 
to reduced oocyst contamination in the drinking water, but 
the magnitude of reduction was greater for the Glasgow 
cohort (100% reduction) than for the Dundee cohort (75%). 
Speciated oocysts were C. parvum, C. bovis, C. ubiquitum, 
and other environmental genotypes. However, C. hominis 
was never isolated from either drinking water supply dur-
ing the study period.
Questionnaire Responses
Few statistically significant differences in demograph-
ic or exposure risk factor variables were found between the 
2 cohorts (Table 3). The relative similarity in demographic 
and risk factor profiles between the Glasgow and Dundee 
cohorts indicated that the populations were comparable.
During the first period, more Glasgow participants con-
sumed bottled water and fewer consumed unboiled drinking 
water than did their Dundee counterparts (p<0.001). Fewer 
participants in each cohort reported swimming after Septem-
ber 2007 than before (p = 0.011 and p = 0.015, respectively).
Serologic Responses
According to univariate analyses, the only significant 
difference was that participants who had no (0) antibody 
response were significantly younger (p<0.001) than those 
with a detectable (>0) serologic response. The importance 
of age to participant serologic response was also assessed 
by using a linear model fitted to the square root of the 
serologic response (to normalize the distribution). In this 
model, age was associated with a statistically significant 
difference in the serologic response (p<0.0001); for each 
additional year of age, the serologic response increased 
by ≈0.35%.
In this study, serologic response to Cryptosporidium 
oocysts was positive for 75% of participants in both co-
horts. The mean serologic response showed an overall in-
crease over the 3-year period, as measured by the propor-
tion with a serologic response (positive/negative, logistic 
model) and the average PPR (linear model) in both cohorts 
(Figure). Both cohorts showed an overall increase over the 
whole 3-year period, as measured by the proportion with 
a serologic response (positive/negative, logistic model) 
and by the average PPR (linear model) (Figure). For pe-
riods 1 and 2, the responses for the Glasgow cohort were 
higher than those for Dundee. However, for the Glasgow 
cohort, the average serologic response (PPR) for period 3 
dropped below that for period 2. This finding coincided 
with the introduction of enhanced filtration treatment at 
Loch Katrine in September 2007. The Glasgow response 
during period 3 was also lower than the Dundee response 
during period 3. Although for period 4, the average sero-
logic response among participants in both cohorts again 
increased, the mean response for Glasgow remained lower 
than that for Dundee.
Further analysis of the data, with the second linear 
mixed effects model fitted to the log of the PPR, indicated 
that mean serologic responses for Glasgow participants 
decreased by 32%, compared with those for Dundee par-
ticipants, after enhanced filtration began at Loch Katrine 
(Table 4). This step-change reduction was statistically as-
sociated with introduction of the new treatment.
The mixed regression analysis of other risk factors 
for exposure to Cryptosporidium oocysts identified 4 posi-
tive findings, although none was statistically significant 
(by Bonferroni correction). Average serologic response to 
Cryptosporidium oocyst antigen was lower among partici-
pants who owned pets than among those who did not (p = 
0.034), higher among those who had been swimming in the 
United Kingdom (p = 0.091), higher among those who con-
sumed water from private supplies (p = 0.087), and lower 
among those who drank bottled water (p = 0.051).
 
Table 1. Participants in study of antibodies against Cryptosporidium  in drinking water, Scotland, UK, 2006–2008 
Participants 
Study period 
1 (2006 Apr–Jul) 2 (2006 Aug–Oct) 3 (2008 Apr–Jul) 4 (2008 Aug–Oct) 
Previous participants* 1,051 750 608 911 
New recruits 0 133 253 0 
Total  1,051 883 861 911 
By city     
 Glasgow 791 671 638 698 
 Dundee 260 212 223 213 
*Donated blood at least 1 time since period 1. 
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Using the interactions model, we investigated the ef-
fect of introducing filtration in Glasgow and how this was 
associated with the sources of water consumed. The coef-
ficients of all of these potential interactions were negative, 
providing evidence that enhanced filtration at Loch Ka-
trine reduced serologic responses among all participants in 
Glasgow, regardless whether they drank only unboiled tap 
water, only bottled water, or both. Serologic response re-
duction was largest among participants who consumed any 
bottled water (either solely or in combination with unboiled 
tap water). However linear, quadratic, and cubic analyses 
indicated no evidence of a direct statistically significant 
association between the reported quantity of bottled wa-
ter consumed and the reduced serologic response (i.e., no 
dose–response effect).
Discussion
Opportunities to study the public health effects of ma-
jor infrastructure changes are uncommon. Blood donors 
provide a convenient sample; they are relatively healthy, 
accessible, and generally cooperative. However, because 
they are predominantly younger to middle-aged adults, 
they are not completely representative of the population. 
Hence, the results of this study might be less applicable to 
children or elderly persons.
In this survey, serologic response to the 27-kDa Cryp-
tosporidium oocyst protein was detected in 64%–75% of 
the total cohort. These findings are consistent with those 
from other populations served by surface-water sources 
(14,19). However, the aspects of this study that advance 
previous knowledge are as follows: the study involved a 
large number of participants in distinct cohorts followed 
over a considerable period, there was a defined intervention 
in one population but not the control population, and we 
sought to collect data on demographics and changes to bio-
logically plausible risk factor exposures each time a partici-
pant donated a blood sample. The prospective cohort study 
design is a relatively robust epidemiologic method; high 
participant numbers enabled robust statistical analyses.
We were primarily interested in evidence of serologic 
response to oocyst exposure spanning a long period, as op-
posed to recent, acute exposure. Other serologic studies 
have assessed IgG serologic responses to the 15/17-kDa 
complex and the 27-kDa protein (13–15,17,19). After ex-
posure to Cryptosporidium oocysts, a serologic response to 
both of these antigen groups usually peaks 4–6 weeks later 
(20). The 15/17-kDa marker declines to baseline levels in 
4–6 months, but the 27-kDa marker remains elevated for at 
least 6–12 months. Because the 27-kDa response is consid-
ered a reliable marker for exposure to Cryptosporidium oo-
cysts, we do not believe that our not investigating serologic 
responses to the 15/17-kDa complex devalues our findings.
 The Western blot method compared each serum sam-
ple with a positive control. Ideally, the positive control se-
rum would have been derived from clinically ill persons, 
but because we did not have access to enough such se-
rum to compare with >3,700 participant samples, we used 
rabbit-derived positive control serum. Although this form 
of calibration is recognized as acceptable for serologic 
studies, it is a possible limitation to this study despite the 
fact that our primary focus was detecting evidence of low 
level oocyst exposure, not confirming a clinical diagnosis 
of infection.
By using several statistical models, we detected a 
marked and dramatic step-change reduction in the seroprev-
alence of antibodies against Cryptosporidium among blood 
donors from the Loch Katrine water supply area after intro-
duction of enhanced water filtration. We detected no corre-
sponding step-change in seroprevalence among the control 
(Dundee) participants. The collated evidence suggests that 
 
Table 2. Concentration of oocysts in drinking water before and 
after September 2007 installation of filtration system in Glasgow, 
Scotland, UK 
Location, period 
Concentration of oocysts/10 L  Reduction, 
% Raw Final 
Dundee    
 Before 0.000850 0.000439 48 
 After  0.001979 0.000115 94 
Glasgow    
 Before  0.004219 0.001320 69 
 After  0.000855 0.000000 100 
 
Table 3. Demographic characteristics of participants in study of antibodies against Cryptosporidium in drinking water, Scotland, UK, 
2006–2008* 
Characteristic 
Location, water filtration status 
Dundee  Glasgow 
Before  After   Before  After  
Mean age, y 42.3 (40.8–43.9) 45.5 (43.8–47.2)  38.8 (37.9–39.6) 42.7 (41.7–43.6) 
Female, % 44.2 (38.3–50.3) 45.2 (38.7–52)  47.1 (43.9–50.3) 43.1 (39.6–46.8) 
Swam in past 12 mo, %  64.6 (58.6–70.2)† 48.3 (41.6–55.1)‡  58.4 (55.1–61.5)† 50.1 (46.4–53.7)‡ 
Have with <5 children, % 8.5 (5.7–12.5)† 9.5 (6.2–14.3)‡  7.4 (5.9–9.2)† 7.5 (5.8–9.7)‡ 
Have pets, % 43.8 (37.9–49.9)† 38.8 (32.4–45.5)‡  32.3 (29.3–35.4)† 30.8 (27.5–34.3)‡ 
Drink unboiled water, % 96.2 (93.1–97.9)† 95.2 (91.4–97.4)‡  89.2 (87.1–91.1)† 88.4 (85.8–90.5)‡ 
Drink bottled water, % 69.2 (63.4–74.5)1 63.2 (56.4–69.4) ‡  77.4 (74.6–80)† 73.7 (70.3–76.8)‡ 
*Before, before filtration in Glasgow (periods 1 and 2); after, after filtration in Glasgow (periods 3 and 4). 
†Percentage of persons who answered “yes” to the question at period 1, period 2, or both. 
‡Percentage of persons who answered “yes” to the question at period 3, period 4, or both. 
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this effect was mainly, if not solely, attributable to the intro-
duction of filtration to the Loch Katrine water supply.
Given the fact that the serologic response levels (PPR) 
continued to increase after the oocysts were eliminated 
from the Loch Katrine water source, this study supports ev-
idence that oocysts from other environmental sources stim-
ulate background immunity levels. Exposure to oocysts 
through other sources (e.g., animal contact and contaminat-
ed food) might be at least as common as exposure through 
contaminated drinking water and might be more likely to 
transmit a higher dose of oocysts.
The study demonstrated that serologic responses to 
Cryptosporidium oocyst exposure were more likely (al-
though not statistically significantly) to be higher among 
participants who ingested water while swimming in an 
indoor swimming pool or drank tap water from a private 
supply than among those who did not. The protective ef-
fect of antibody levels induced by such exposures is un-
known; clinical cases of cryptosporidiosis have also been 
associated with swimming pools and private water supplies 
(21,22). More frequent use of water for recreational and 
other purposes might therefore increase the overall level of 
oocyst exposure, but it might also confer some resistance to 
infection on a per-event basis (23).
The observation in this study that age correlates with 
increased serologic response to Cryptosporidium antigen 
has been observed among persons with gastrointestinal and 
other infections (24–26). Children are more susceptible to 
gastrointestinal infection (including cryptosporidiosis) than 
adults, partly because adults have higher serum/mucosal 
antibody levels induced by the number of pathogen expo-
sures during their lifetime (15,26).
Because partial (probably protective) immunity devel-
ops among persons with previous or ongoing exposure to 
Cryptosporidium oocysts, contamination of drinking-water 
sources might not necessarily manifest itself as detectable 
cases or outbreaks among local residents, but it might af-
fect casual consumers more. Increased rates of clinical dis-
ease might not be the inevitable result of ongoing chronic 
low-level contamination of the water supply (4). The ap-
parently complete removal of Cryptosporidium oocysts 
from drinking water supplied by Loch Katrine might have 
decreased the risk for waterborne illness. However, this 
reduction of low-level immune system stimulation might 




Table 4. The coefficients and significance of the terms used in the second linear mixed effects model fitted to the log of the percentage 
positive response* 
Model element  
Coefficient Coefficient exponentiated 
(95% CI) 
% Difference 
 (95% CI) Value (95% CI) p alue 
Intercept  2.79 (2.61 to 2.98) 0.0000 16.32 (13.57 to 19.63) NA 
City†  0.09 (0.02 to 0.15) 0.0077 1.09 (1.02 to 1.17) 19 (5 to 33) 
Pre/post filtration periods‡  0.29 (0.24 to 0.33) 0.0000 1.33 (1.27 to 1.4) 66 (54 to 79) 
Period 2 vs. period 1§  0.16 (0.1 to 0.22) 0.0000 1.17 (1.1 to 1.25) 34 (20 to 49) 
Period 4 vs. period 3¶  0.12 (0.06 to 0.19) 0.0004 1.13 (1.06 to 1.21) 26 (11 to 42) 
Pre/postfiltration, Glasgow vs. Dundee#  0.17 (0.22 to 0.12) 0.0000 0.84 (0.8 to 0.88) 32 (40 to 23) 
Period 2 vs. period 1, Glasgow vs. Dundee**  0.06 (0 to 0.12) 0.0690 1.06 (1 to 1.13) 12 (1 to 26) 
Period 4 vs. period 3, Glasgow vs. Dundee††  0.07 (0 to 0.14) 0.0475 1.07 (1 to 1.15) 14 (0 to 29) 
Minimum donor age‡‡  0.02 (0.01 to 0.02) 0.0000 1.02 (1.01 to 1.02) NA 
*Calculated for study of antibodies against Cryptosporidium spp. in drinking water, Scotland, 2006–2009. NA, not applicable.  
†Negative value implies fewer/lower serologic responses in Glasgow than in Dundee, averaged over the 4 periods.  
‡Positive value implies more/higher responses in periods 3 and 4 compared with periods 1 and 2, averaged over the periods and cities.  Periods 3 and 4 
are post filtration in Glasgow.  
§Positive value implies more/higher responses during period 2 compared with period 1, averaged over the cities.  
¶Positive value implies more/higher responses during period 4 compared with period 3 averaged over the cities.  
#Negative value implies fewer/lower responses after filtration (period 3 and 4) at Glasgow than at Dundee.  This is a comparison of the change in 
response from periods 1 and 2 with periods 3 and 4 in Glasgow with the same change in Dundee. 
**Positive value implies more/higher change in responses at Glasgow than at Dundee in period 2 compared with period 1.  
††Positive value implies more/higher change in responses at Glasgow than at Dundee in period 4 compared with period 3.  
‡‡Earliest age at which a sample was collected from a donor.  
 
Figure. Mean percentage positive response (PPR) (IgG) to the 
27-kDa antigen of Cryptosporidium oocysts among blood donors 
in Glasgow and Dundee, Scotland, 2006–2008. This graph 
represents the (model estimate) geometric mean PPR for an 
average participant followed up for the 4 time periods. The plot 
does not represent the proportion of participants for whom serologic 
response to the 27-kDa antigen was positive.
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